- Home
- LNAI vs ZENV Comparison
LNAI vs ZENV Comparison
Compare LNAI & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNAI | ZENV |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3M | 16.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | LNAI | ZENV |
|---|---|---|
| Price | $0.40 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 283.4K | ★ 441.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $0.25 |
| 52 Week High | $1.66 | $2.16 |
Technical Indicators
Market Signals| Indicator | LNAI | ZENV |
|---|---|---|
| Relative Strength Index (RSI) | 31.14 | 20.23 |
| Support Level | N/A | N/A |
| Resistance Level | $1.00 | $1.00 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 5.51 | 11.25 |
Price Performance
Historical ComparisonAbout LNAI Lunai Bioworks Inc.
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.